Tindamax

Purohit Navigation Portfolio

Having been widely used in Europe for 30-plus years, Tindamax® (tinidazole) was to be launched in the US, where it would be positioned against the decades-long leader, metronidazole. To launch in the US trichomoniasis market, we knew the campaign had to be a “knockout”… and it was! Positioned as a better option because it performed as effectively as metronidazole but with a low incidence of GI side effects, the product became quite the contender.

Heralded by industry giants like Med Ad News as a creative best, the Tindamax campaign proved to be a success for our client, too.